Extended kinase profile and properties of the protein kinase inhibitor nilotinib-Reference-Cited by-同舟云学术

Extended kinase profile and properties of the protein kinase inhibitor nilotinib

Published:2010-03 Issue:3 Volume:1804 Page:445-453
ISSN:1570-9639
Container-title:Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics

Author:

Manley Paul W.,Drueckes Peter,Fendrich Gabriele,Furet Pascal,Liebetanz Janis,Martiny-Baron Georg,Mestan Jürgen,Trappe Jörg,Wartmann Markus,Fabbro Doriano

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics,Analytical Chemistry

Reference51 articles.

1. Regulation of the c-Abl and BCR-Abl tyrosine kinases;Hantschel;Nat. Rev. Mol. Cell. Biol.,2004

2. Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation;Filippakopoulos;Cell,2008

3. Charting the molecular network of the drug target Bcr-Abl;Brehme;Proc. Natl. Acad. Sci.,2009

4. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells;Druker;Nat. Med.,1996

5. Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia;Manley;Biochim. Biophys. Acta,2005

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?;Cancers;2024-08-28

2. Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors;European Journal of Pharmacology;2024-05

3. Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies;BMC Chemistry;2024-02-12

4. Tyrosine Kinase Inhibitor-associated Cerebral Arterial Occlusive Disease Treated with High-flow Bypass Surgery: A Case Report;NMC Case Report Journal;2023-12-31

5. Nilotinib alleviates paraquat-induced hepatic and pulmonary injury in rats via the Nrf2/Nf-kB axis;International Immunopharmacology;2023-11